DrugPatentWatch Database Preview

Details for Patent: 8,778,962

Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,778,962 protect, and when does it expire?

Patent 8,778,962 protects AFINITOR DISPERZ and AFINITOR and is included in two NDAs.

Protection for AFINITOR DISPERZ has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has one hundred and eighty-one patent family members in twenty-eight countries.

Summary for Patent: 8,778,962

Title:	Treatment of solid tumors with rapamycin derivatives
Abstract:	Rapamycin derivatives have interesting effects in the treatment of solid tumours, optionally in combination with a chemotherapeutic agent.
Inventor(s):	Lane; Heidi (Basel, CH), O'Reilly; Terence (Basel, CH), Wood; Jeanette Marjorie (Biel-Benken, CH)
Assignee:	Novartis Pharmaceuticals Corporation (East Hanover, NJ)
Application Number:	13/546,686
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,778,962
Patent Claim Types: see list of patent claims	Use; Dosage form; Delivery;

Drugs Protected by US Patent 8,778,962

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Novartis Pharm	AFINITOR DISPERZ	everolimus	TABLET, FOR SUSPENSION;ORAL	203985-001	Aug 29, 2012		RX	Yes	No					Y
Novartis Pharm	AFINITOR DISPERZ	everolimus	TABLET, FOR SUSPENSION;ORAL	203985-002	Aug 29, 2012		RX	Yes	No					Y
Novartis Pharm	AFINITOR DISPERZ	everolimus	TABLET, FOR SUSPENSION;ORAL	203985-003	Aug 29, 2012		RX	Yes	Yes					Y
Novartis	AFINITOR	everolimus	TABLET;ORAL	022334-003	Jul 9, 2010	AB	RX	Yes	No					Y
Novartis	AFINITOR	everolimus	TABLET;ORAL	022334-001	Mar 30, 2009	AB	RX	Yes	Yes					Y
Novartis	AFINITOR	everolimus	TABLET;ORAL	022334-004	Mar 30, 2012	AB	RX	Yes	No					Y
Novartis	AFINITOR	everolimus	TABLET;ORAL	022334-002	Mar 30, 2009	AB	RX	Yes	No					Y

Foreign Priority and PCT Information for Patent: 8,778,962

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0104072.4	Feb 19, 2001
United Kingdom	0124957.2	Oct 17, 2001

International Family Members for US Patent 8,778,962

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2002250968
Brazil	0207378
Canada	2438504
Canada	2860306
Canada	2994779
China	104083365
China	104116738